Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chitra Hosing

Showing results (211-220 of 234) with videos related to

Pageof 24
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2015
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic LeukemiaPiyanuch Kongtim, Uday Popat, Antonio Jimenez, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2018
Radiation Therapy as an Effective Salvage Strategy for Secondary CNS LymphomaSarah A Milgrom, Chelsea C Pinnix, T Linda Chi, et al.
American Journal of Hematology|October 10, 2019
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantationSamer A Srour, Rima M Saliba, Maria C B Bittencourt, et al.
Blood|February 2, 2018
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletionBetül Oran, Rima M Saliba, Yudith Carmazzi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2012
Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantationStefan O Ciurea, Victor Mulanovich, Rima M Saliba, et al.
Blood|June 2, 2016
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantationTakuya Sekine, David Marin, Kai Cao, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2016
Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution ReviewChelsea C Pinnix, Jatin J Shah, Hubert Chuang, et al.
Transplantation and Cellular Therapy|May 23, 2022
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple MyelomaAimaz Afrough, Leonard C Alsfeld, Denái R Milton, et al.
Cancer|July 13, 2016
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantationSameh Gaballa, Isabell Ge, Riad El Fakih, et al.
The Journal of Rheumatology|February 19, 2013
Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trialEmily W Hung, Maureen D Mayes, Roozbeh Sharif, et al.
Pageof 24

Showing results (211-220 of 234) with videos related to

Sort By:
Pageof 24
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2015
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic LeukemiaPiyanuch Kongtim, Uday Popat, Antonio Jimenez, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2018
Radiation Therapy as an Effective Salvage Strategy for Secondary CNS LymphomaSarah A Milgrom, Chelsea C Pinnix, T Linda Chi, et al.
American Journal of Hematology|October 10, 2019
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantationSamer A Srour, Rima M Saliba, Maria C B Bittencourt, et al.
Blood|February 2, 2018
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletionBetül Oran, Rima M Saliba, Yudith Carmazzi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2012
Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantationStefan O Ciurea, Victor Mulanovich, Rima M Saliba, et al.
Blood|June 2, 2016
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantationTakuya Sekine, David Marin, Kai Cao, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2016
Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution ReviewChelsea C Pinnix, Jatin J Shah, Hubert Chuang, et al.
Transplantation and Cellular Therapy|May 23, 2022
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple MyelomaAimaz Afrough, Leonard C Alsfeld, Denái R Milton, et al.
Cancer|July 13, 2016
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantationSameh Gaballa, Isabell Ge, Riad El Fakih, et al.
The Journal of Rheumatology|February 19, 2013
Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trialEmily W Hung, Maureen D Mayes, Roozbeh Sharif, et al.
Pageof 24